Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
07/20/2000 | WO2000004149A3 Compositions and methods for therapy and diagnosis of prostate cancer |
07/20/2000 | WO2000003727A9 Engineered proteins for analyte sensing |
07/20/2000 | WO2000003246A9 A system for cell-based screening |
07/20/2000 | WO2000002897A9 Delta cleavage products and methods based thereon |
07/20/2000 | WO1999064835A9 Screening method for dehydrogenase oligomerisation modulators |
07/20/2000 | WO1999064048A9 Inhibitors of hiv reverse transcriptase |
07/20/2000 | WO1999063094A9 Nucleotide and protein sequences of gpr1 and methods based thereon |
07/20/2000 | WO1999054353A3 Human nucleic acid sequences of normal uterus tissue |
07/20/2000 | WO1999013336A9 Noninvasive transdermal systems for detecting analytes |
07/20/2000 | WO1997025042A8 Use of an agonist of ppar-alpha and ppar-gamma for the treatment of syndrom x |
07/20/2000 | DE19901815A1 Engine oil quality determination by differential quartz crystal oscillation measurement as indicator of deposited carboxylic acid weight using longer-chain chemical model incorporated in ceramic temperature-resistant gel-sol coating |
07/20/2000 | DE19901008A1 Peptide zur Inhibierung von HPV E6-Proteinen Peptides for inhibition of HPV-E6 proteins |
07/20/2000 | DE19860343C1 Quantitative determination of airborne microorganisms comprises using a portable collecting device and a modified commercial Aspergillus immunoassay |
07/20/2000 | DE19858338C1 Measuring depth-dependent frequency distribution of pore component, especially in tipped cohesion-less loose rock, involves deriving vertical stress pore distribution functions via histograms |
07/20/2000 | DE19858336C1 Method to measure depth-dependent frequency distribution of pore-dependent physical characteristics, especially tips of incohesive loose stones; involves producing histograms of physical characteristics to determine distribution function |
07/20/2000 | DE10000670A1 Apparatus for measuring the moisture vapour permeability of a shoe in milligrams per square centimeter per hour or grams per square centimeter per day |
07/20/2000 | CA2697598A1 Compounds and methods to inhibit or augment an inflammatory response |
07/20/2000 | CA2509345A1 Bacterial cell component-unresponsive model mouse |
07/20/2000 | CA2371938A1 Method for electrochemically detecting nucleic acid-oligomer hybridisation events |
07/20/2000 | CA2370042A1 Regulators of the pct or smoothened pathway, compositions and uses related thereto |
07/20/2000 | CA2362484A1 Herbicide target gene and methods |
07/20/2000 | CA2361204A1 Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses |
07/20/2000 | CA2360597A1 Mitochondrial dna damage as a predictor of coronary atherosclerotic heart disease |
07/20/2000 | CA2360588A1 Human homologues of proteins regulated by circadian rhythms |
07/20/2000 | CA2360581A1 A novel method for designing protein kinase inhibitors |
07/20/2000 | CA2360464A1 Human peptidases |
07/20/2000 | CA2360054A1 Reagent system and method for increasing the luminescence of lanthanide (iii) macrocyclic complexes |
07/20/2000 | CA2360044A1 Lateral flow test strip |
07/20/2000 | CA2360013A1 Optimized high-throughput analytical system |
07/20/2000 | CA2359798A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith |
07/20/2000 | CA2359795A1 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
07/20/2000 | CA2359555A1 A breath test for the detection of various diseases |
07/20/2000 | CA2359504A1 Novel compounds |
07/20/2000 | CA2359486A1 Neisseria meningitidis polypeptide basb052 |
07/20/2000 | CA2359392A1 Use of apoptosis inducing agents in the treatment of (auto)immune diseases |
07/20/2000 | CA2359349A1 A method for introducing substances into cells, and use of said method |
07/20/2000 | CA2359335A1 Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
07/20/2000 | CA2359132A1 Bone marrow-specific protein |
07/20/2000 | CA2359067A1 Polypeptide variants with altered effector function |
07/20/2000 | CA2358908A1 Bone stimulating factor |
07/20/2000 | CA2358748A1 Reagents and methods useful for detecting diseases of the breast |
07/20/2000 | CA2358693A1 Anti-ccr4 antibodies and methods of use therefor |
07/20/2000 | CA2358510A1 Methods for detecting an analyte of interest using tyramide coating technology |
07/20/2000 | CA2358506A1 Method and device for determining an analyte |
07/20/2000 | CA2325359A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
07/19/2000 | EP1020727A1 Method for assaying hepatitis c virus |
07/19/2000 | EP1020726A1 Immunologic test method and immunologic test kit |
07/19/2000 | EP1020725A1 Process for determining impurities in refractory materials |
07/19/2000 | EP1020724A2 Apparatus for exhaust gas analysis |
07/19/2000 | EP1020722A2 Hydrophilic polyurethane-coated chloride-selective electrodes |
07/19/2000 | EP1020721A1 Nitrogen oxides detection method, and sensor element for detection of nitrogen oxides |
07/19/2000 | EP1020533A1 Method for judging the possibility of the onset of sheep leukemia |
07/19/2000 | EP1020532A1 Method for assaying biological specimens for substances contained in the components thereof and reagent to be used in this method |
07/19/2000 | EP1020521A1 Fas Ligand inhibitor ( FLINT ) compositions and uses thereof |
07/19/2000 | EP1020519A1 Minor histocompatibility antigens and their use in the diagnosis and treatment of tumors |
07/19/2000 | EP1020516A2 Leptospira vaccine antigens for the prevention of leptospirosis |
07/19/2000 | EP1019947A2 Mass spectrometers and methods for rapid screening of libraries of different materials |
07/19/2000 | EP1019887A2 Fluorescent cyanine dyes |
07/19/2000 | EP1019738A1 Method and apparatus for in-situ measurement of polymer cure status |
07/19/2000 | EP1019731A1 High speed chromatographic method for hemoglobin variants screening and quantification of hemoglobins a 2? and f |
07/19/2000 | EP1019730A1 STRIP TEST FOR DIAGNOSING ALLERGIES $i(IN-VITRO) |
07/19/2000 | EP1019729A1 Method for predicting drug response, in particular igf-i |
07/19/2000 | EP1019728A1 Method of activating a novel ligand regulatory pathway |
07/19/2000 | EP1019727A1 Immunoassay for the detection of cancer |
07/19/2000 | EP1019726A1 Prevention of sudden infant death |
07/19/2000 | EP1019725A2 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens |
07/19/2000 | EP1019724A1 Diagnostic tests and kits for clostridium difficile |
07/19/2000 | EP1019723A1 Method and apparatus for rapid analysis of analytes in biological samples |
07/19/2000 | EP1019722A1 Polymeric fluorophores enhanced by moieties providing a hydrophobic and conformationally restrictive microenvironment |
07/19/2000 | EP1019721A1 Chromophores in the preparation of novel tandem conjugates |
07/19/2000 | EP1019720A1 Combinatorial process for preparing tetrahydroquinoline libraries |
07/19/2000 | EP1019719A2 Method for determining the state of substances containing keratin and suitable devices and means therefor |
07/19/2000 | EP1019718A1 Device and method for examining cells using the patch-clamp method |
07/19/2000 | EP1019717A1 Diagnostic device and method |
07/19/2000 | EP1019716A1 Methods for screening drugs to predict tardive dyskinesia |
07/19/2000 | EP1019715A1 Techniques and systems for analyte detection |
07/19/2000 | EP1019713A1 Radiation activation and screening of catalyst libraries for catalyst evaluation and reactors therefor |
07/19/2000 | EP1019711A1 Methods and materials for optimization of electronic hybridization reactions |
07/19/2000 | EP1019699A1 System and method for automatically detecting malignant cells and cells having malignancy-associated changes |
07/19/2000 | EP1019660A1 Method and system for the determination of a ternary refrigerant mixture composition |
07/19/2000 | EP1019546A1 Methods for measurement of lymphocyte function |
07/19/2000 | EP1019545A1 Methods and reagents for preserving rna in cell and tissue samples |
07/19/2000 | EP1019542A1 Methods to modulate blood pressure and diagnose bartter's syndrome type iii |
07/19/2000 | EP1019534A1 Multifunctional linking reagents for synthesis of branched oligomers |
07/19/2000 | EP1019529A1 A method of treating cancer |
07/19/2000 | EP1019525A1 Chemiluminescence compositions and methods |
07/19/2000 | EP1019513A1 Ikr-1 and ikr-2, protein kinases which are related to the i kappa b kinases |
07/19/2000 | EP1019510A1 Porcine circoviruses, vaccines and diagnostic reagents |
07/19/2000 | EP1019509A2 Protein involved in abscisic acid signalling |
07/19/2000 | EP1019508A1 Tnf-related death ligand |
07/19/2000 | EP1019507A1 Amino-terminally truncated rantes as chemokine antagonists |
07/19/2000 | EP1019506A1 101 human secreted proteins |
07/19/2000 | EP1019503A1 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides |
07/19/2000 | EP1019496A1 In vitro sorting method |
07/19/2000 | EP1019495A1 Transgenic model comprising tcr alpha and beta chains |
07/19/2000 | EP1019491A1 Production of avian embryonic germ (eg) cell lines by prolonged culturing of pgcs, use thereof for cloning and chimerization |
07/19/2000 | EP1019490A2 Methods for modulating hematopoiesis and vascular growth |
07/19/2000 | EP1019453A1 Aromatic-substituted xanthene dyes |
07/19/2000 | EP1019441A2 ANTI-BiP-ANTIBODIES IN RHEUMATOID ARTHRITIS, METHOD AND TEST KITS FOR DETECTING THEM |
07/19/2000 | EP1019438A1 Apoptosis-related compounds and their use |